rs12583
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004393.6(DAG1):c.*830G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 152,586 control chromosomes in the GnomAD database, including 4,618 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.24 ( 4604 hom., cov: 33)
Exomes 𝑓: 0.24 ( 14 hom. )
Consequence
DAG1
NM_004393.6 3_prime_UTR
NM_004393.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.10
Publications
19 publications found
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophy type 2PInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- isolated asymptomatic elevation of creatine phosphokinaseInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.265 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DAG1 | NM_004393.6 | c.*830G>T | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000308775.7 | NP_004384.5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.238 AC: 36121AN: 151976Hom.: 4591 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
36121
AN:
151976
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.236 AC: 116AN: 492Hom.: 14 Cov.: 0 AF XY: 0.268 AC XY: 81AN XY: 302 show subpopulations
GnomAD4 exome
AF:
AC:
116
AN:
492
Hom.:
Cov.:
0
AF XY:
AC XY:
81
AN XY:
302
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
2
AN:
14
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
1
AN:
8
European-Finnish (FIN)
AF:
AC:
36
AN:
214
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
77
AN:
248
Other (OTH)
AF:
AC:
0
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.238 AC: 36165AN: 152094Hom.: 4604 Cov.: 33 AF XY: 0.230 AC XY: 17087AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
36165
AN:
152094
Hom.:
Cov.:
33
AF XY:
AC XY:
17087
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
11168
AN:
41470
American (AMR)
AF:
AC:
2931
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
664
AN:
3464
East Asian (EAS)
AF:
AC:
44
AN:
5182
South Asian (SAS)
AF:
AC:
417
AN:
4830
European-Finnish (FIN)
AF:
AC:
1925
AN:
10586
Middle Eastern (MID)
AF:
AC:
83
AN:
292
European-Non Finnish (NFE)
AF:
AC:
18169
AN:
67970
Other (OTH)
AF:
AC:
520
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1408
2816
4225
5633
7041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
234
AN:
3478
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
not provided Other:1
May 13, 2011
Leiden Muscular Dystrophy (DAG1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.